Lobbying Information
Subject Matters
- Economic Development
- Employment and Training
- Energy
- Environment
- Government Procurement
- Health
- Industry
- Infrastructure
- Intellectual Property
- Internal Trade
- International Development
- International Relations
- International Trade
- Labour
- National Security/Security
- Privacy and Access to Information
- Regional Development
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- Seeking funding from the Strategic Innovation Fund to allow for the construction of facilities to advance Canada’s vaccine and biomanufacturing capabilities.
Policies or Program
- Engage with the federal government on building Canada's vaccine and biomanufacturing ecosystem.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Business Development Bank of Canada (BDC)
-
Employment and Social Development Canada (ESDC)
-
Export Development Canada (EDC)
-
Finance Canada (FIN)
-
Health Canada (HC)
-
House of Commons
-
Infrastructure Canada (INFC)
-
Innovation, Science and Economic Development Canada (ISED)
-
National Research Council (NRC)
-
Natural Sciences and Engineering Research Council (NSERC)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
In-house Corporation Details
Description of activities
Resilience Biotechnologies (RBI), formerly Therapure Biopharma, is a wholly owned subsidiary of National Resilience, Inc. RBI is an Ontario-based Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of complex biologics. RBI’s mission is to support for Canadian vaccine and therapeutics production and serve as a long-term partner for Canadian pharmaceutical manufacturing.
Responsible officer name and position during the period of this registration
Sankalp Vashishtha,
Vice President / General Manager
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
2585 Meadowpine Blvd.
Mississauga, ON L5N 8H9
Canada
Telephone number:
905-286-6200
Parent Company Information
- National Resilience, Inc.
-
3115 Merryfield Row, Suite 200
San Diego, CA 92121
United States of America
Subsidiary Beneficiary Information
Resilience Biotechnologies, Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
No lobbyists added
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Erin Minthorn,
Head of Government Affairs |
No public offices held
